It's the easiest way profit from the "Green Gold Rush"!
We've uncovered the best way to reap all of the rewards of the marijuana industry at a fraction of the risk.
They're called ancillary companies - and they could be your ticket to marijuana millions.
Ancillary companies, often called "pick-and-shovel" plays, allow you to benefit from an industry's success without directly investing in it.
They're great as low-risk, high-reward plays, because while they profit from the marijuana industry, they aren't fully dependent on it.
It's like investing in Levi Strauss & Co. during the California Gold Rush of the 1840s and 50s. Levi's didn't mine gold, but it supplied the garments for the thousands of men who did.
The company's slogan back then was even "For Men Who Toil."
Since then, Levi Strass & Co. has become the largest pants manufacturer in the world.
It's important to note that you've got to pick the right ancillary stocks to see those double- and triple-digit returns - not all businesses related to cannabis will succeed.
The best ancillary plays, like the ones we're about to show you in this report, offer both share price potential and industry growth.
The gains we've seen from these stocks already are impressive. But the gains we're likely to see are downright stunning (and we doubt you'll find them anywhere else).
To find the best possible returns, you need to look for stocks with these two critical characteristics...
First, we look for companies whose share prices are on the rise. These are stocks that have enjoyed astronomical growth and are poised to continue upward.
These stocks could mint you returns of 100% or more just from share-price growth alone.
Second, we only consider ancillary stocks immersed in industries that are growing alongside the burgeoning marijuana industry.
This way, you know you're getting stocks that are positioned to grow rapidly as more states - and countries - legalize.
By using this checklist, you can easily find the most valuable low-risk, high-reward "pot stock" plays out there.
And we've done the heavy lifting for you. As promised, we've handpicked a list of the most valuable ancillary marijuana stocks for you today...
Radient Technologies Inc. (OTCMKTS: RDDTF)
Price: $0.66
Radient Technologies is not a producer of cannabis, but rather an extractor of cannabis products.
The Canadian tech company focuses on extracting naturally occurring compounds from organic materials, like soybeans.
America’s Green Gold Rush Is Just Getting Started – Claim Your Stake Now: At this very moment, big investment firms and members of the Fortune 500 are building enormous war chests. They’re preparing to push billions upon billions of dollars into the cannabis market – and they could strike at any moment. So right here – right now – you have a once-in-a-lifetime opportunity to beat them to the punch and stake your claim. Click here...
The company uses its proprietary microwave-assisted processing - or MAP - technology to provide substantially higher yields and purity than conventional natural extraction. This method is also superior to other extraction techniques because it reduces the reliance on harsh chemicals that can adversely affect the quality of the extracted oils.
Now that cannabis is widely legal in the United States - and fully legal in Canada - the company has pivoted to include cannabinoid extractions. Cannabinoid oils are a hot market right now, as these oils are used in edibles, vaporizers, and ointments. Radient's technology is ideal for extracting cannabinoid oil for both recreational and medicinal purposes.
Shareholders were pleased when the company announced an expansion project in early 2018, which will potentially add 100,000 square feet of extraction facilities to its footprint.
But perhaps the most attractive thing about Radient is the company's strategic partnerships with bigger cannabis "fish" like Aurora Cannabis. Aurora recently acquired 19.8% of Radient's undiluted common shares. The partnership allows Radient to fund its upcoming expansion, while Aurora benefits from Radient's state-of-the-art equipment and pristine cannabis oils.
And while Aurora is Radient's most well-known deal, the company also recently signed with Terra Life Sciences, a private, rapidly growing Canadian manufacturer of pharmaceuticals. Terra Life owns and operates two pharma-grade facilities that manufacture highly potent pharmaceuticals.
While the Radient is still small, with a market cap of just over $174.12 million, it shows promise with steady revenue growth over the last seven quarters.
Overall, Radient is positioned to continue leading the pack at a time when cannabinoid extraction demand is on the rise, making it a solid momentum play.
Auxly Cannabis Group Inc. (OTCMKTS: CBWTF)
Price: $1.02
Marijuana's legal gray area makes it difficult for banks to lend to cannabis companies.
Most banks are hesitant to lend because they fear retaliation from federal regulators. As a result, cannabis companies often resort to selling shares to gain needed capital, diluting their shares in the process.
Auxly Cannabis Group, formerly known as Cannabis Wheaton Income Corp., solves this problem by using a form of financing called streaming. Put simply, streaming works when an investor provides the funds for expansion, and in return, it gets "paid" with a portion of the goods produced or a portion of the revenue derived from the goods. In some cases, the investor receives both.
Auxly invests in small cannabis companies that need funds to expand facility space. In return, the company receives a portion of the cannabis produced and a small equity share in the companies it is partnering with.
In other words, Auxly is a royalty marijuana stock.
The company has active partnerships with nearly two dozen small cannabis companies that yield over 230,000 kilograms of product a year. These partnerships create a cash balance of $26 million Canadian, or slightly over $21 million U.S., for the company. And with current liabilities of only $685,000 Canadian ($555,836 U.S.), the company would have little trouble meeting its obligations. In fact, the company has virtually zero recurring costs and daily maintenance expenditures to worry about.
See how to conquer America's most controversial – and lucrative – industry: He was once marijuana’s biggest enemy… but now, former Speaker of the House John Boehner is advising Americans to go “ALL IN” on cannabis. To see his entire shocking prediction, click here.
The company's founders are all veteran cannabis industry professionals, including one of the founders of Canopy Growth, the largest cannabis producer in the world
Scotts Miracle-Gro Co. (NYSE: SMG)
Price: $69.95
Scotts Miracle-Gro, the well-known worldwide leader in lawn and garden care, is also a must-have marijuana pick-and-shovel play.
In 2015, Scotts' CEO, Jim Hagedorn, purchased two companies that specialize in soil and fertilizer for cannabis growers. Then, one year later, he invested a 75% stake in Gavita International, a hydroponics equipment company.
What Is Hydroponics?
Hydroponics is the method of growing plants without soil by using mineral nutrient solutions in a water solvent - a popular and highly effective way of growing cannabis, especially in densely populated areas.
As of December 2016, Scotts' hydroponics business generated roughly $250 million annually, according to Bloomberg, and that number is expected to grow well into 2020.
Since then, the company has also acquired leading brands Agrolux, Botanicare, General Hydroponics, and Vermicrop to capitalize on cannabis legalization. And its most recent acquisition, Can-Filters, is sure to amplify its cannabis industry exposure tenfold.
In fact, CEO Jim Hagedorn called the company "the top hydroponic brand in air movement and filtration systems."
Scotts spent $72.2 million on the acquisition. The company has now invested $565 million since March 2015, beefing up its stake in the marijuana industry.
As a mid-cap company that has its hands in multiple sectors, its growth has been steady and reliable.
Over the past two years, SMG stock has risen a solid 67.4%. That's on top of an impressive dividend yield of 3.15%.
Former Speaker of the House John Boehner just joined the cannabis industry’s biggest players to cover everything you need to know about America’s next unstoppable economic revolution.
At our live event, they explained how cannabis could become our next $1 trillion industry… every step to full legalization… how the average American can profit from this explosive phenomenon… and John Boehner’s SHOCKING marijuana prediction.
To see a full rebroadcast of this extraordinary event, click here.